Literature DB >> 16967467

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.

M Leidenius1, K Salmenkivi, K von Smitten, P Heikkilä.   

Abstract

BACKGROUND: Our aim was to evaluate the prevalence of and risk factors for tumour-positive sentinel node (SN) findings in patients with ductal carcinoma in situ (DCIS).
METHODS: Altogether 1,470 patients underwent sentinel node biopsy (SNB) between April 2001 and March 2005 in our unit. According to a histopathological review, 11 of them had microinvasive and 74 pure DCIS and were included in the study.
RESULTS: Five patients (7%) with pure DCIS had SN metastases. Three of them had isolated tumour cells (ITC) only. Axillary clearance without further metastatic findings was performed in three patients. The median histological size of DCIS was larger, 50 (45-60) mm in patients with metastatic SN findings than the median of 18 (2-110) mm in those with tumour-negative SN, P=0.0103. All five patients with metastatic SN findings underwent mastectomy. Metastatic SN findings were detected in one (9%) patient with microinvasive DCIS.
CONCLUSIONS: Metastatic SN findings in patients with pure DCIS may be a sign of missed invasion. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16967467     DOI: 10.1002/jso.20581

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.

Authors:  Mira Heinonen; Annabrita Hemmes; Kaisa Salmenkivi; Kotb Abdelmohsen; Suvi-Tuuli Vilén; Marko Laakso; Marjut Leidenius; Tuula Salo; Sampsa Hautaniemi; Myriam Gorospe; Päivi Heikkilä; Caj Haglund; Ari Ristimäki
Journal:  J Pathol       Date:  2011-04-11       Impact factor: 7.996

Review 2.  Is DCIS breast cancer, and how do I treat it?

Authors:  N Bijker; M Donker; J Wesseling; G J den Heeten; E J Th Rutgers
Journal:  Curr Treat Options Oncol       Date:  2013-03

3.  Sentinel lymph node biopsy in patients with breast ductal carcinoma in situ: Chinese experiences.

Authors:  Xiao Sun; Hao Li; Yan-Bing Liu; Zheng-Bo Zhou; Peng Chen; Tong Zhao; Chun-Jian Wang; Zhao-Peng Zhang; Peng-Fei Qiu; Yong-Sheng Wang
Journal:  Oncol Lett       Date:  2015-07-10       Impact factor: 2.967

4.  Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?

Authors:  Melissa Pilewskie; Maria Karsten; Julia Radosa; Anne Eaton; Tari A King
Journal:  Ann Surg Oncol       Date:  2016-03-09       Impact factor: 5.344

5.  Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

Authors:  Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; Riccardo Arisio; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 6.  The impact of sentinel lymph node biopsy and magnetic resonance imaging on important outcomes among patients with ductal carcinoma in situ.

Authors:  Todd M Tuttle; Tatyana Shamliyan; Beth A Virnig; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 7.  Microinvasive carcinoma of the breast.

Authors:  Simonetta Bianchi; Vania Vezzosi
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

Review 8.  Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer.

Authors:  Tibor Takács; Attila Paszt; Károly Szentpáli; Katalin Ormándi; Máté Lázár; István Pálka; Zsuzsa Kahán; György Lázár
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

9.  The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.

Authors:  Christine Tunon-de-Lara; Marie Pierre Chauvet; Marie Christine Baranzelli; Marc Baron; Jean Piquenot; Guillaume Le-Bouédec; Fréderique Penault-Llorca; Jean-Rémi Garbay; Jérôme Blanchot; Joëlle Mollard; Véronique Maisongrosse; Simone Mathoulin-Pélissier; Gaëtan MacGrogan
Journal:  Ann Surg Oncol       Date:  2015-03-17       Impact factor: 5.344

10.  Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion.

Authors:  Zhi-Bin Wan; Hong-Yi Gao; Lian Wei; An-Qin Zhang; Jiang-Yu Zhang; Yi Wang; Dong-Dong Wang; Yan Zhang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.